GUNILLA ANDREW-NIELSEN, Head of Department of Clinical Trials and Special Permissions, Swedish Medical Products Agency

Gunilla Andrew-Nielsen has held her current position as Head of Clinical Trial and Special Permission at the MPA in Sweden since 2011. Since the early 1990s, she has held various positions within global R&D in the pharma industry including project and training management and later as Director of Quality Assurance.